🔴 Gilead Sciences is trading 4.16% down today amid a 5.19% XBI decline

Gilead Sciences is trading at ARS 70,325.00 (-4.16%) amid biotech-sector pressure.

• Biotech ETF XBI fell 5.19% during the session, alongside a broader growth-stock sell-off.
• Recent reporting also described biotech weakness during a technology-led market rout.
• No company-specific announcement clearly explains the decline. Gilead’s November 5 Phase 3 Livdelzi results were positive and do not provide a clear reason for the drop.